Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Clinical trial NCT03434730 · COMPLETED

Trial details

NCT number: NCT03434730
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Acute Leukemia Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorder Non Hodgkin Lymphoma Hodgkin Lymphoma Leukemia

Start date: 2018-02-07
Primary completion: 2025-04-18
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.